1-6 of 6
Michaela Dostalova Merkerova, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Small Noncoding RNAs As Novel Semi-Invasive Markers of Patient Survival in Myelodysplastic Syndromes

Michaela Dostalova Merkerova, PhD MSc, Andrea Hrustincova, Zdenek Krejcik, David Kundrat, Katarina Szikszai, PhD, Jaroslav Cermak, Jitka Vesela, Monika Hruba, Monika Belickova, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3004.
https://doi.org/10.1182/blood-2019-126520
Published: 2019
Journal Articles

RUNX1 Mutation Accompanied with Dysregulated Cellular Senescence in Lower-Risk Myelodysplastic Syndrome Patients Is Associated with Disease Progression

Monika Hruba, Jitka Vesela, Hana Votavova, PhD, Michaela Dostalova Merkerova, PhD MSc, David Kundrat, Katarina Szikszai, PhD, Marie Lauermanova, MD, Zuzana Zemanova, PhD, Anna Jonasova, MD PhD, Jaroslav Cermak, MD PhD, Monika Belickova, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4230.
https://doi.org/10.1182/blood-2019-131150
Published: 2019
Journal Articles

Relationship between Altered Gene Expression and DNA Methylation of the DLK1-DIO3 region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Michaela Dostalova Merkerova, PhD MSc, Hana Remesova, Zdenek Krejcik, Nikoleta Loudova, Andrea Hrustincova, Katarina Szikszai, PhD, Jitka Vesela, MSc, Jaroslav Cermak, MD PhD, Anna Jonasova, MD, Monika Belickova, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5496.
https://doi.org/10.1182/blood-2018-99-113378
Published: 2018
Journal Articles

Deregulated Expression of Long Noncoding RNAs H19 , LEF1-AS1 , TCL6, and WT1-AS1 Predicts Poor Outcome of Patients with Myelodysplastic Syndromes

Michaela Dostalova Merkerova, PhD MSc, Nikoleta Loudova, Katarina Szikszai, PhD, Zdenek Krejcik, Jiri Klema, Pavla Pecherkova, Andrea Hrustincova, Jitka Vesela, MSc, Jaroslav Cermak, MD PhD, Anna Jonasova, MD, Monika Belickova, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5498.
https://doi.org/10.1182/blood-2018-99-116071
Published: 2018
Journal Articles

Mutations in RUNX1 and TP53 Genes Predict Progression in Patients with Lower-Risk Myelodysplastic Syndrome

Monika Hruba, MSc, Jitka Vesela, MSc, Hana Votavova, PhD, Michaela Dostalova Merkerova, PhD MSc, Katarina Szikszai, PhD, Marie Lauermannova, MD, Zuzana Zemanova, PhD, Anna Jonasova, MD, Jaroslav Cermak, MD PhD, Monika Belickova, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5519.
https://doi.org/10.1182/blood-2018-99-118048
Published: 2018
Journal Articles

Putative Monosomy 5 In Myelodysplastic Syndromes (MDS) Is Probably Resulting From Chromothripsis

Zuzana Zemanova, Kyra Michalova, PhD, Halka Buryova, Jana Brezinova, PhD, Libuse Lizcova, Karla Kostylkova, Iveta Sarova, PhD, Silvia Izakova, Sarka Ransdorfova, Zdenek Krejcik, Michaela Dostalova Merkerova, PhD, Magda Siskova, MD, Anna T Jonasova, MD, Radana Neuwirtova, MD, PhD, Jaroslav Cermak, PhD
Journal: Blood
Blood (2013) 122 (21): 1559.
https://doi.org/10.1182/blood.V122.21.1559.1559
Published: 2013